In the Media

InMed Files Patent Application for its Cannabinoid Biosynthesis Program
InMed Pharmaceuticals Inc. (TSX:IN; OTCQX:IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary biosynthesis platform technology to develop novel therapeutics for the treatment of...
Source: City Biz List
Are cannabinoids the new wave for treating human diseases?
While many of the stigmas and steadfast opinions against marijuana use have begun to dissolve, the U.S. government still currently classifies marijuana as a Schedule 1...
Source: Healthcare Global
CBD Research Makes Headway with New Medical Treatments
CBD Researchers Make Strides Medical and Biotech research firms are getting a lot closer to bringing Cannabinoid, or CBD remedies into the main stream. Further,...
Source: Phil Hulett and Friends Podcast